CrossrefInfokarte
HIF prolyl hydroxylase inhibitors and malignancy: tumor-promoting risks and tumor-suppressive effects mediated by tumor-associated macrophages
Folia Pharmacologica Japonica · 2026-11-01 · 161 (6) · 454-456
DOI: 10.1254/fpj.26070 ↗Abstract
Kein Abstract verfügbar.
EUVIMED